This page lists the SEC filings reported by LA JOLLA PHARMACEUTICAL CO.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2023-02-14 | RTW INVESTMENTS, LP | LA JOLLA PHARMACEUTICAL CO | 0 | 0.0% | EDGAR |
| SC 13D/A | 2022-08-29 | GARDNER LEWIS ASSET MANAGEMENT L P | LA JOLLA PHARMACEUTICAL CO | 0 | 0.0% | EDGAR |
| SC 13D | 2022-08-29 | GARDNER LEWIS ASSET MANAGEMENT L P | LA JOLLA PHARMACEUTICAL CO | 1,504,791 | 6.0% | EDGAR |
| SC 13D/A | 2022-08-24 | TANG CAPITAL PARTNERS LP | LA JOLLA PHARMACEUTICAL CO | 0 | 0.0% | EDGAR |
| SC 13D/A | 2022-07-12 | TANG CAPITAL PARTNERS LP | LA JOLLA PHARMACEUTICAL CO | 9,607,934 | 38.6% | EDGAR |
| SC 13G/A | 2022-02-14 | RTW INVESTMENTS, LP | LA JOLLA PHARMACEUTICAL CO | 2,590,932 | 9.3% | EDGAR |
| SC 13D/A | 2021-12-02 | TANG CAPITAL PARTNERS LP | LA JOLLA PHARMACEUTICAL CO | 9,607,934 | 34.9% | EDGAR |
| SC 13G/A | 2021-07-12 | BlackRock Inc. | LA JOLLA PHARMACEUTICAL CO | 384,695 | 1.4% | EDGAR |
| SC 13D/A | 2021-05-27 | TANG CAPITAL PARTNERS LP | LA JOLLA PHARMACEUTICAL CO | 9,804,204 | 35.7% | EDGAR |
| SC 13G/A | 2021-02-12 | RTW INVESTMENTS, LP | LA JOLLA PHARMACEUTICAL CO | 2,397,378 | 8.8% | EDGAR |
| SC 13G/A | 2021-01-29 | BlackRock Inc. | LA JOLLA PHARMACEUTICAL CO | 1,477,499 | 5.4% | EDGAR |
| SC 13G/A | 2021-01-04 | Broadfin Capital, LLC | LA JOLLA PHARMACEUTICAL CO | 0 | 0.0% | EDGAR |
| SC 13D/A | 2020-09-11 | TANG CAPITAL PARTNERS LP | LA JOLLA PHARMACEUTICAL CO | 9,405,490 | 34.4% | EDGAR |
| SC 13D/A | 2020-08-18 | TANG CAPITAL PARTNERS LP | LA JOLLA PHARMACEUTICAL CO | 9,127,121 | 33.4% | EDGAR |
| SC 13D/A | 2020-07-29 | LA JOLLA PHARMACEUTICAL CO | TETRAPHASE PHARMACEUTICALS INC | 7,263,236 | 100.0% | EDGAR |
| SC 13D/A | 2020-07-01 | LA JOLLA PHARMACEUTICAL CO | TETRAPHASE PHARMACEUTICALS INC | 1,085,000 | 14.9% | EDGAR |
| SC 13D/A | 2020-06-26 | LA JOLLA PHARMACEUTICAL CO | TETRAPHASE PHARMACEUTICALS INC | 1,085,000 | 14.9% | EDGAR |
| SC 13D | 2020-06-22 | LA JOLLA PHARMACEUTICAL CO | TETRAPHASE PHARMACEUTICALS INC | 1,085,000 | 14.9% | EDGAR |
| SC 13D/A | 2020-06-05 | TANG CAPITAL PARTNERS LP | LA JOLLA PHARMACEUTICAL CO | 8,695,474 | 31.9% | EDGAR |
| SC 13G/A | 2020-02-14 | PERCEPTIVE ADVISORS LLC | LA JOLLA PHARMACEUTICAL CO | 0 | 0.0% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.